Floatz logo

Marijuana

Peripheral Nervous System Diseases

Center for Medicinal Cannabis ResearchPhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Peripheral Nervous System Diseases cohort.

Asset / SponsorPhaseRating
Capsaicin
Samyang Biopharmaceuticals Corporation
Phase 3A
Oxcarbamezapine
Søren H. Sindrup
Phase 4BB
Ngx-4010, 8% Capsaicin Patch
NeurogesX
Phase 3BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
United States Naval Medical Center, San Diego
Phase 4BB
Adezunap
Apurano Pharmaceuticals GmbH
Phase 3B

View all 11 →

Same molecule, other indications

Marijuana is also rated in:

CannabisDormant
BB
Indicative ·
71 / 100
View asset →
HIV NeuropathyDormant
BB
Indicative ·
65 / 100
View asset →
Diabetic Peripheral Neuropathic PainDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →